Global Genomics Personalized Health Market: By Technology (NGS platforms, RT-PCR, Microarray, and Genetic Analyzers); End Users (Research and Diagnostic centers, Academics, and Others); Test Type (Oncology Testing, Infectious Disease Testing, Genetic Disease Testing, Autoimmune Disease Testing, and Others); Region—Market Forecast and Analysis for 2024–2032
Global genomics personalized health market was valued at US$ 17.0 billion in 2023 and is projected to attain a valuation of US$ 57.9 billion by 2032 at a CAGR of 14.6% During the Forecast Period 2024–2032. Read More
We Are Trusted By These Great Companies!
- Published On: 01-Jul-2024 | Format:
![pdf]()
![powerpoint]()
![excel]()
| Report ID: AA0623453
| Report ID: AA0623453Speak to Analyst
Base Year 2023
Historic Year 2019-2022
Forecast Year 2024-2032
No Of Pages 210
Total Figures 100
Total Tables 90
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
